220 related articles for article (PubMed ID: 11994407)
1. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span.
Jin HK; Carter JE; Huntley GW; Schuchman EH
J Clin Invest; 2002 May; 109(9):1183-91. PubMed ID: 11994407
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.
Miranda SR; Erlich S; Friedrich VL; Gatt S; Schuchman EH
Gene Ther; 2000 Oct; 7(20):1768-76. PubMed ID: 11083499
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of Niemann-Pick disease.
Jin HK; Schuchman EH
Mol Ther; 2003 Dec; 8(6):876-85. PubMed ID: 14664789
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
[TBL] [Abstract][Full Text] [Related]
5. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology.
Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR
J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580
[TBL] [Abstract][Full Text] [Related]
6. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease.
Passini MA; Macauley SL; Huff MR; Taksir TV; Bu J; Wu IH; Piepenhagen PA; Dodge JC; Shihabuddin LS; O'Riordan CR; Schuchman EH; Stewart GR
Mol Ther; 2005 May; 11(5):754-62. PubMed ID: 15851014
[TBL] [Abstract][Full Text] [Related]
7. Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse.
Passini MA; Bu J; Fidler JA; Ziegler RJ; Foley JW; Dodge JC; Yang WW; Clarke J; Taksir TV; Griffiths DA; Zhao MA; O'Riordan CR; Schuchman EH; Shihabuddin LS; Cheng SH
Proc Natl Acad Sci U S A; 2007 May; 104(22):9505-10. PubMed ID: 17517638
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction.
Yeyati PL; Agmon V; Fillat C; Dinur T; Dagan A; Desnick RJ; Gatt S; Schuchman EH
Hum Gene Ther; 1995 Aug; 6(8):975-83. PubMed ID: 7578419
[TBL] [Abstract][Full Text] [Related]
9. Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice.
Miranda SR; Erlich S; Friedrich VL; Haskins ME; Gatt S; Schuchman EH
Transplantation; 1998 Apr; 65(7):884-92. PubMed ID: 9565090
[TBL] [Abstract][Full Text] [Related]
10. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.
Horinouchi K; Erlich S; Perl DP; Ferlinz K; Bisgaier CL; Sandhoff K; Desnick RJ; Stewart CL; Schuchman EH
Nat Genet; 1995 Jul; 10(3):288-93. PubMed ID: 7670466
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures.
Erlich S; Miranda SR; Visser JW; Dagan A; Gatt S; Schuchman EH
Blood; 1999 Jan; 93(1):80-6. PubMed ID: 9864149
[TBL] [Abstract][Full Text] [Related]
12. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
Schuchman EH
FEBS Lett; 2010 May; 584(9):1895-900. PubMed ID: 19944693
[TBL] [Abstract][Full Text] [Related]
13. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
Suchi M; Dinur T; Desnick RJ; Gatt S; Pereira L; Gilboa E; Schuchman EH
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3227-31. PubMed ID: 1565614
[TBL] [Abstract][Full Text] [Related]
14. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease.
Ikegami M; Dhami R; Schuchman EH
Am J Physiol Lung Cell Mol Physiol; 2003 Mar; 284(3):L518-25. PubMed ID: 12495943
[TBL] [Abstract][Full Text] [Related]
15. Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function.
Marathe S; Miranda SR; Devlin C; Johns A; Kuriakose G; Williams KJ; Schuchman EH; Tabas I
Hum Mol Genet; 2000 Aug; 9(13):1967-76. PubMed ID: 10942425
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.
Schuchman EH
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S48-57. PubMed ID: 20040312
[TBL] [Abstract][Full Text] [Related]
17. Injection of mouse and human neural stem cells into neonatal Niemann-Pick A model mice.
Sidman RL; Li J; Stewart GR; Clarke J; Yang W; Snyder EY; Shihabuddin LS
Brain Res; 2007 Apr; 1140():195-204. PubMed ID: 17289003
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice.
Dhami R; Passini MA; Schuchman EH
Mol Ther; 2006 Mar; 13(3):556-64. PubMed ID: 16214420
[TBL] [Abstract][Full Text] [Related]
19. Toward gene therapy for Niemann-Pick disease (NPD): separation of retrovirally corrected and noncorrected NPD fibroblasts using a novel fluorescent sphingomyelin.
Dinur T; Schuchman EH; Fibach E; Dagan A; Suchi M; Desnick RJ; Gatt S
Hum Gene Ther; 1992 Dec; 3(6):633-9. PubMed ID: 1482703
[TBL] [Abstract][Full Text] [Related]
20. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease.
Barbon CM; Ziegler RJ; Li C; Armentano D; Cherry M; Desnick RJ; Schuchman EH; Cheng SH
Mol Ther; 2005 Sep; 12(3):431-40. PubMed ID: 16099409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]